iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB) Shares Down 0.3% – What’s Next?

iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDBGet Free Report) shares traded down 0.3% during trading on Thursday . The stock traded as low as $35.26 and last traded at $35.29. Approximately 15,156 shares changed hands during mid-day trading, a decline of 24% from the average session volume of 19,857 shares. The stock had previously closed at $35.39.

iShares LifePath Target Date 2030 ETF Stock Performance

The firm has a market capitalization of $76.93 million, a P/E ratio of 20.07 and a beta of 0.57. The stock has a 50-day moving average of $34.91 and a 200 day moving average of $34.13.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ITDB. Susquehanna International Group LLP bought a new stake in shares of iShares LifePath Target Date 2030 ETF during the third quarter valued at approximately $335,000. Rothschild Investment LLC bought a new position in iShares LifePath Target Date 2030 ETF in the 4th quarter worth approximately $148,000. Finally, Capital Advisors Ltd. LLC raised its position in iShares LifePath Target Date 2030 ETF by 21.8% in the 1st quarter. Capital Advisors Ltd. LLC now owns 3,430 shares of the company’s stock worth $112,000 after purchasing an additional 613 shares during the last quarter.

iShares LifePath Target Date 2030 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2030 ETF (ITDB) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2030 ITDB was launched on Oct 17, 2023 and is issued by BlackRock.

Featured Stories

Receive News & Ratings for iShares LifePath Target Date 2030 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2030 ETF and related companies with MarketBeat.com's FREE daily email newsletter.